← back to search

Peng Huang

Wildlife Conservation Society · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, RNA modifications and cancer, and Mitochondrial Function and Pathology.
h-index
94
citations
40,791
works
588
NIH funding
primary concept
email

Recent publications

The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.
2026cited by 1position: contributordoi
KRAS<sup>G12D</sup> mutation promotes pancreatic tumorigenesis by suppressing sirtuin three via the guanine nucleotide exchange factor RCC1.
2026cited by 0position: contributordoi
Mitochondrial metabolism as a pharmacological target for cancer therapeutics
Pharmacological Reviews 2026cited by 0position: contributordoi
Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic flux
Nature Cancer 2025cited by 13position: middledoi
Tryptophan Metabolite Indole‐3‐Aldehyde Induces AhR and c‐MYC Degradation to Promote Tumor Immunogenicity
Advanced Science 2025cited by 13position: middledoi
Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity.
2025cited by 6position: contributordoi
Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic flux.
2025cited by 5position: contributordoi
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer.
2025cited by 4position: contributordoi
Targeting oncogenic activation of FLT3/SREBP/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipids.
2025cited by 2position: contributordoi
Targeting ROS in cancer: rationale and strategies
Nature Reviews Drug Discovery 2024cited by 531position: lastdoi
Targeting ROS in cancer: rationale and strategies.
2024cited by 313position: contributordoi
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles
Nature Communications 2024cited by 51position: middledoi
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles.
2024cited by 30position: contributordoi
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Nature Communications 2024cited by 26position: lastdoi
Squalene-epoxidase-catalyzed 24(S),25-epoxycholesterol synthesis promotes trained-immunity-mediated antitumor activity
Cell Reports 2024cited by 20position: middledoi
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma
Cell Death and Differentiation 2024cited by 19position: middledoi
The Association Between Tumor Radiomic Analysis and Peritumor Habitat‐Derived Radiomic Analysis on Gadoxetate Disodium‐Enhanced <scp>MRI</scp> With Microvascular Invasion in Hepatocellular Carcinoma
Journal of Magnetic Resonance Imaging 2024cited by 19position: middledoi
Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
Frontiers in Pharmacology 2024cited by 17position: lastdoi
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
2024cited by 17position: contributordoi
Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity
The EMBO Journal 2024cited by 16position: middledoi
High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma.
2024cited by 16position: contributordoi
The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism
Redox Biology 2024cited by 15position: middledoi
Extraction, purification, structural characterization, and bioactivities of Ginkgo biloba leave polysaccharides: A review
International Journal of Biological Macromolecules 2024cited by 15position: lastdoi
Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.
2024cited by 13position: contributordoi
HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2.
2024cited by 9position: contributordoi
The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism.
2024cited by 6position: contributordoi
Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.
2024cited by 4position: contributordoi
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer.
2024cited by 3position: contributordoi
SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer.
2024cited by 2position: contributordoi
SQLE-mediated squalene metabolism is critical for mitochondrial biogenesis and tumor development in K-ras-driven cancer
2024cited by 0position: contributordoi

Grants

FMitF: Track I: Synthesizing Semantic Checkers for Runtime Verification of Production Distributed Systems
NSF2318937$750,0002023–2027PIRePORTER
CNS Core: Small: Intelligent Fault Injection to Expose and Reproduce Production-Grade Bugs in Cloud Systems
NSF2317698$446,5372023–2025PIRePORTER
CAREER: Towards Gray-Fault Tolerant Cloud through Harnessing and Enhancing System Observability
NSF2317751$429,0662023–2026PIRePORTER
CNS Core: Small: Intelligent Fault Injection to Expose and Reproduce Production-Grade Bugs in Cloud Systems
NSF2149664$500,0002021–2023PIRePORTER
CAREER: Towards Gray-Fault Tolerant Cloud through Harnessing and Enhancing System Observability
NSF1942794$365,9482020–2023PIRePORTER
CRII: CSR: Toward Understanding and Automatically Detecting Specious Configuration in Large Systems
NSF1755737$174,9552018–2021PIRePORTER

Frequent collaborators

Shijun Wen · Tibet University36 papers (2012–2025) · 29 papers (2021–2026)Rui‐Hua Xu · Henan Medical University23 papers (2012–2023)Yumin Hu · Sun Yat-sen University22 papers (2012–2025)Panpan Liu · Sun Yat-sen University19 papers (2016–2025)Huai‐Qiang Ju · Sun Yat-sen University12 papers (2013–2023)Wenhua Lu · Sun Yat-sen University11 papers (2016–2024)Jinyun Liu · Academy of Medical Sciences10 papers (2014–2025)Zhao-Lei Zeng · Sun Yat-sen University10 papers (2013–2023) · 8 papers (2019–2025)Xiaojun Xia · Zhejiang International Studies University8 papers (2019–2025)Bingling Luo · Sun Yat-sen University8 papers (2013–2022)Yun‐Xin Lu · Sun Yat-sen University7 papers (2015–2020)Xiaojun Xia · Baylor College of Medicine7 papers (2021–2024)Paul J. Chiao · University of Houston7 papers (2014–2021)Dan Xie · Capital Medical University7 papers (2014–2020)Jing Yang · Shanxi Agricultural University7 papers (2015–2023)Penghui Zhou · Huaiyin Institute of Technology6 papers (2019–2025)Dong-liang Chen · Sun Yat-sen University6 papers (2013–2020)Zexian Liu · Sixth Affiliated Hospital of Sun Yat-sen University6 papers (2019–2023)